These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 23709757

  • 1. Against all odds: anti-IgE for intrinsic asthma?
    Lommatzsch M, Korn S, Buhl R, Virchow JC.
    Thorax; 2014 Jan; 69(1):94-6. PubMed ID: 23709757
    [Abstract] [Full Text] [Related]

  • 2. [Dermatological implications of omalizumab, an anti-IgE antibody].
    Di Lucca-Chrisment J.
    Rev Med Suisse; 2015 Apr 01; 11(468):779-80, 782-3. PubMed ID: 26021140
    [Abstract] [Full Text] [Related]

  • 3. Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments.
    Pelaia G, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Maselli R.
    Curr Drug Targets; 2015 Apr 01; 16(2):171-8. PubMed ID: 25523898
    [Abstract] [Full Text] [Related]

  • 4. Omalizumab in asthma: an update on recent developments.
    Humbert M, Busse W, Hanania NA, Lowe PJ, Canvin J, Erpenbeck VJ, Holgate S.
    J Allergy Clin Immunol Pract; 2014 Apr 01; 2(5):525-36.e1. PubMed ID: 25213045
    [Abstract] [Full Text] [Related]

  • 5. Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis.
    Félix Toledo R, Negro Alvarez JM, Miralles López JC.
    Allergol Immunopathol (Madr); 2002 Apr 01; 30(2):94-9. PubMed ID: 11958741
    [Abstract] [Full Text] [Related]

  • 6. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
    D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov 01; 1(3):225-31. PubMed ID: 19075985
    [Abstract] [Full Text] [Related]

  • 7. Omalizumab for severe asthma: efficacy beyond the atopic patient?
    Domingo C.
    Drugs; 2014 Apr 01; 74(5):521-33. PubMed ID: 24691707
    [Abstract] [Full Text] [Related]

  • 8. Anti-IgE antibodies for the treatment of asthma.
    Buhl R.
    Curr Opin Pulm Med; 2005 Jan 01; 11(1):27-34. PubMed ID: 15591885
    [Abstract] [Full Text] [Related]

  • 9. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002 Jan 01; 16(5):380-6. PubMed ID: 12408744
    [Abstract] [Full Text] [Related]

  • 10. Anti-IgE for chronic asthma in adults and children.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD003559. PubMed ID: 16625585
    [Abstract] [Full Text] [Related]

  • 11. Anti-IgE for chronic asthma in adults and children.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2004 Apr 19; (3):CD003559. PubMed ID: 15266491
    [Abstract] [Full Text] [Related]

  • 12. Anti-IgE for chronic asthma.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2003 Apr 19; (3):CD003559. PubMed ID: 12917972
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-IgE therapy: clinical utility and mechanistic insights.
    Logsdon SL, Oettgen HC.
    Curr Top Microbiol Immunol; 2015 Apr 19; 388():39-61. PubMed ID: 25553794
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Longitudinal study of the expression of FcεRI and IgE on basophils and dendritic cells in association with basophil function in two patients with severe allergic asthma treated with Omalizumab.
    Pereira Santos MC, Campos Melo A, Caetano A, Caiado J, Mendes A, Pereira Barbosa M, Branco Ferreira M.
    Eur Ann Allergy Clin Immunol; 2015 Mar 19; 47(2):38-40. PubMed ID: 25781192
    [Abstract] [Full Text] [Related]

  • 17. Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE.
    Lowe PJ, Renard D.
    Br J Clin Pharmacol; 2011 Aug 19; 72(2):306-20. PubMed ID: 21392073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children.
    Hill DA, Siracusa MC, Ruymann KR, Tait Wojno ED, Artis D, Spergel JM.
    Allergy; 2014 May 19; 69(5):674-7. PubMed ID: 24611974
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.